EBCC 2024: results from groundbreaking breast cancer studies
EBCC 2024: results from groundbreaking breast cancer studies
it
Prof. Giuseppe Curigliano
The achievements of Europa Donna Italia: not just the Breast Unit
it
Rosanna D'Antona
Role of PET/MRI in the management of early breast cancer
it
Dr. Rosa Di Micco
Contrast-enhanced mammography and MRI to improve breast cancer detection
en
Prof. Thomas Helbich
Europa Donna turns 30. The activities
it
Marzia Zambon
Risk stratification in early breast cancer
it
Prof. Nicola Fusco
Lymphedema risk: prediction models based on AI and machine learning
en
Prof. Tim Rattay
The future of AI in oncology: diagnostic and decision-making algorithms
it
Prof. Giuseppe Curigliano
Relazione tra attivitĂ fisica e outcome clinici nel cancro della mammella
it
Dr. Antonio Di Meglio
Trastuzumab Deruxtecan in HER2-Low Breast Cancer
en
Prof. Janice Walshe
The role of Europa Donna in the organization of EBCC 24
it
Rosanna D'Antona
New method, PET-MRI + fluoroestradiol: FESTA study begins
it
Dr. Rosa Di Micco
Metastatic carcinoma: liquid biopsy in daily clinical practice
it
Prof. Nicola Fusco